- Case report
- Open Access
Pancreatic insulinoma co-existing with gastric GIST in the absence of neurofibromatosis-1
© Alabraba et al; licensee BioMed Central Ltd. 2009
Received: 04 November 2008
Accepted: 13 February 2009
Published: 13 February 2009
Gastrointestinal stromal tumours (GIST) frequently occur in patients with neurofibromatosis type 1 (NF-1). It has been reported that GIST may co-exist with pancreatic endocrine tumors but this has only been in association with NF-1.
A 76 year old woman presented with a 12 month history of hypoglycaemia symptoms. Abdominal CT scan demonstrated a 13 mm insulinoma localized in the tail of her pancreas. She was commenced on diazoxide and later underwent surgery for enucleation of insulinoma when a small (< 1 cm) incidental tumour was discovered on her stomach wall which was identified as GIST.
This is the first case report of a pancreatic insulinoma co-existing with a GIST in a patient without NF-1. In addition, we make the first report of rapidly growing cystic GIST recurrence following resection of a primary GIST tumour.
Gastro-entero-pancreatic (GEP NE) tumours have an incidence of around 30/million/population/year . Pancreatic islet cell tumours including insulinomas represent the 2nd most common type of GEP NE tumour after carcinoid tumour .
Co-existent GIST and NET in patients with NF-1
Papilla of Vater
Papilla of Vater; domatostatinoma
Pancreatic head gastrinoma
Duodenum neuroendocrine carcinoma
Here we report the first case of insulinoma associated with a GIST in a patient not diagnosed with NF-1 as confirmed by the pre-operative endocrine assessment.
A 76 year old woman presented with a 12 month history of hypoglycaemia symptoms. The patient underwent a series of tests including measurement of overnight fasting plasma glucose, measurement of plasma levels of glucose; insulin; and c-peptide during a hypoglycaemic episode, measurement of urinary sulphonylurea, and radiological imaging with a CT scan. Abdominal CT scan demonstrated a 13 mm insulinoma localized in the tail of her pancreas. She was commenced on diazoxide and later underwent surgery for enucleation of insulinoma when a small (< 1 cm) incidental tumour was discovered on her stomach wall. The small incidental tumour was an exophytic gastric wall lesion that had not been detected pre-operatively and revealed no suspicious features suggestive of invasion or spread on intra-operative inspection. For this reason the lesion was excised with diathermy off the surface of the gastric wall, the defect being closed with Polydioxanone suture, and no frozen sections were taken to assess invasion/spread. Macroscopically the lesion was completely excised. The nature of the lesion was unknown at this time. Recovery was uncomplicated and she was discharged home a week later.
The first important message in our case is that a GIST can occur simultaneously with an insulinoma in the absence of NF-1. The GIST tumour was only incidentally discovered by the operating surgeon during enucleation of the insulinoma in our case. The literature contains only 9 published reports of the simultaneous occurrence of GIST and GEP NE tumour in NF-1 patients [7–12] (Table 1). None of the reported cases of co-existent GIST and GEP NE tumours in NF-1 patients has ever involved an insulinoma and in fact the only report of hypoglycaemia associated with GIST was attributed to a rare paraneoplastic syndrome caused by over-expression of insulin-like growth factor II  in an advanced gastric GIST. It is debatable whether or not incomplete excision of the gastric GIST could have been avoided but because the gastric GIST was only discovered incidentally, showed no suspicious features on gross inspection, and the opinion of another experienced surgeon sought during the surgical procedure was in concordance with that of the operating surgeon, it was decided to proceed with simple excision of the gastric lesion with minimal dissection as was done.
The other unique message in our case is the observed rapid recurrence of the GIST following the resection of the primary gastric wall GIST. Small GISTs, like the initial one in our case, are usually an incidental surgical finding, while large tumours are usually symptomatic. In our case, following resection of the insulinoma and the small incidental gastric GIST, the GIST recurred locally with rapid enlargement. The tumour showed marked cystic transformation probably as result of central necrosis and liquefaction. The reason for the rapid recurrence of the GIST is unclear but evidence from animal studies demonstrates that a primary tumour can inhibit its remote metastases via circulating angiostatin such that after primary tumour removal, the inhibition is removed and metastases become vascularized and grow rapidly . We suspect that in our case, the primary GIST may have had a suppressive effect on satellite micro-lesions which was lost when the GIST was resected leading to aggressive local recurrence. An additional finding is the unique cystic change in the recurrent GIST. Although it has been reported that a rapidly growing primary GIST can form a lobulated cystic mass lesion , such rapid cystic mass recurrence has never been reported in the literature following resection of a small incidental tumour. We were surprised by the recurrence of the GIST lesion as the initial GIST of the gastric wall had a low mitotic rate and also a low ki-67 index. We accept that the mechanism of the GIST 'recurrence' may be one of four possibilities: true recurrence of the primary gastric wall GIST, undetected primary at initial surgery when the stomach wall GIST was removed, residual tumour from initial surgery when the stomach wall GIST was removed, or metastatic disease related to the primary gastric wall GIST.
In summary, this is the first case report of a non-NF-1 patient that had a pancreatic insulinoma co-existent with a GIST, and also, the first case report of a GIST that underwent rapid cystic recurrence following resection of the primary GIST lesion. Unfortunately our unique case report raises more questions than provides answers because there are very few cases of NF-1-related concurrent GEP NE tumours and GISTs and also very little understanding of the prognostic implications of such concurrent tumours. Available evidence suggests that mutations in the NF-1 gene might be involved in the pathogenesis of GIST in NF-1 patients . However it is unknown if the same mutation exists in NF-1 patients with co-existent GISTs and GEP NE tumours, and more importantly, it is unknown if there are such mutations in non-NF-1 patients with co-existent GISTs and GEP NE tumours. Our unit routinely performs gene mutation analysis on GIST tumours but unfortunately there is a 2% failure rate in our mutation analysis and attempts to analyse the primary GIST lesion in this case were unsuccessful. Completing this mutation analysis would have greatly enhanced our understanding of the unusual co-existence of this tumour in the setting of a non-NF-1 patient, and, also shed more light on its unusual pattern of recurrence.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
- Reznek RH: CT/MRI of neuroendocrine tumours. Cancer Imaging. 2006, 6: S163-S177. 10.1102/1470-7330.2006.9037.PubMed CentralView ArticlePubMedGoogle Scholar
- Leotlela PD, Jauch A, Holtgreve-Grez H, Thakker RV: Genetics of neuroendocrine and carcinoid tumours. Endocr Relat Cancer. 2003, 10: 437-450. 10.1677/erc.0.0100437.View ArticlePubMedGoogle Scholar
- Ghrist TD: Gastrointestinal involvement in neurofibromatosis. Arch Intern Med. 1963, 112: 357-362.View ArticlePubMedGoogle Scholar
- Miettinen M, Fetsch JF, Sobin LH, Lasota J: Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases. Am J Surg Pathol. 2006, 30: 90-96. 10.1097/01.pas.0000176433.81079.bd.View ArticlePubMedGoogle Scholar
- Fujisawa T, Osuga T, Maeda M, Sakamoto N, Maeda T, Sakaguchi K, Onishi Y, Toyoda M, Maeda H, Miyamoto K, Kawaraya N, Kusumoto C, Nishigami T: Malignant endocrine tumor of the pancreas associated with von Recklinghausen's disease. J Gastroenterol. 2002, 37: 59-67. 10.1007/s535-002-8135-x.View ArticlePubMedGoogle Scholar
- Perren A, Wiesli P, Schmid S, Montani M, Schmitt A, Schmid C, Moch H, Komminoth P: Pancreatic endocrine tumors are a rare manifestation of the neurofibromatosis type 1 phenotype: molecular analysis of a malignant insulinoma in a NF-1 patient. Am J Surg Pathol. 2006, 30: 1047-1051. 10.1097/00000478-200608000-00018.View ArticlePubMedGoogle Scholar
- Karatzas G, Kouraklis G, Karayiannakis A, Patapis P, Givalos N, Kaperonis E: Ampullary carcinoid and jejunal stromal tumour associated with von Recklinghausen's disease presenting as gastrointestinal bleeding and jaundice. Eur J Surg Oncol. 2000, 26: 428-429. 10.1053/ejso.1999.0911.View ArticlePubMedGoogle Scholar
- Kramer K, Siech M, Strater J, Aschoff AJ, Henne-Bruns D: [GI hemorrhage with fulminant shock induced by jejunal gastrointestinal stromal tumor (GIST) coincident with duodenal neuroendocrine carcinoma (NET) + neurofibromatosis (NF) – case report and review of the literature]. Z Gastroenterol. 2005, 43: 281-288. 10.1055/s-2004-813810.View ArticlePubMedGoogle Scholar
- Kramer K, Hasel C, Aschoff AJ, Henne-Bruns D, Wuerl P: Multiple gastrointestinal stromal tumors and bilateral pheochromocytoma in neurofibromatosis. World J Gastroenterol. 2007, 13: 3384-3387.PubMed CentralPubMedGoogle Scholar
- Lisewski D, Ryan S, Lim EM, Frost F, Nguyen H: Concomitant compostite adrenal phoechromocytoma, multipte gastric stromal tumours and pseudohermaphrodism in a patient with von Recklinghausen's disease. Int Semin Surg Oncol. 2006, 3: 11-10.1186/1477-7800-3-11.PubMed CentralView ArticlePubMedGoogle Scholar
- Rizzo S, Bonomo S, Moser A, Bottura D, Castellini C, Mazzola F, Lauro E, Vicenzi L, Betresini B, Angeli G, Brazzarola P, D'Azzò G, Rosa G: [Bilateral pheochromocytoma associated with duodeno-jejunal GIST in patient with von Recklinghausen disease: report of a clinical case]. Chir Ital. 2001, 53: 243-246.PubMedGoogle Scholar
- Teramoto S, Ota T, Maniwa A, Matsui T, Itaya N, Aoyagi K, Kusanagi H, Narita M: Two von Recklinghausen's disease cases with pheochromocytomas and gastrointestinal stromal tumors (GIST) in combination. Int J Urol. 2007, 14: 73-74. 10.1111/j.1442-2042.2006.01601.x.View ArticlePubMedGoogle Scholar
- Usui M, Matsuda S, Suzuki H, Hirata K, Ogura Y, Shiraishi T: Somatostatinoma of the papilla of Vater with multiple gastrointestinal stromal tumors in a patient with von Recklinghausen's disease. J Gastroenterol. 2002, 37: 947-953. 10.1007/s005350200159.View ArticlePubMedGoogle Scholar
- Pagogna S, Zanini N, Tomassetti P, Casadei R, Grottola T, Ricci C, Minni F: Neuroendocrine Tumor of the Pancreas and GIST: Is there a Correlation?. J Pancreas (Online). 2004, 6: 501-502.Google Scholar
- Guiteau J, Fanucchi M, Folpe A, Staley CA, Kooby DA: Hypoglycemia in the setting of advanced gastrointestinal stromal tumor. Am Surg. 2006, 72: 1225-1230.PubMedGoogle Scholar
- O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994, 79: 315-328. 10.1016/0092-8674(94)90200-3.View ArticlePubMedGoogle Scholar
- Ding G, Yang J, Cheng S, Kai L, Nan L, Zhang S, Cong W, Wu M: A rare case of rapid growth of exophytic gastrointestinal stromal tumor of the stomach. Dig Dis Sci. 2005, 50: 820-823. 10.1007/s10620-005-2646-1.View ArticlePubMedGoogle Scholar
- Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, Pauwels P, De Wever I, Vermeesch JR, de Raedt T, De Paepe A, Speleman F, van Oosterom A, Messiaen L, Legius E: Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet. 2006, 15: 1015-1023. 10.1093/hmg/ddl016.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.